The paradoxical association of regression with a poor prognosis in melanoma contrasted with a good prognosis in keratoacanthoma

Cancer Research

Volumn 56, Issue 5, 1996, Pages 937-940

  Prehn, Richmond T ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER REGRESSION; CANCER SURVIVAL; CELL DIFFERENTIATION; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENCE; KERATOACANTHOMA; MELANOMA; METASTASIS; PRIORITY JOURNAL; REVIEW;

HUMANS; MELANOMA; NEOPLASM REGRESSION, SPONTANEOUS; PROGNOSIS; SKIN NEOPLASMS;

EID: 0030023023     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Clark, W. H., Jr., Elder, D. E., Guerry, D. V., Braitman, L. E., Trock, B. J , Schultz, D., Synnestvedt, M., and Halpern, A C. Model predicting survival in stage 1 melanoma based on tumor progression. J Natl. Cancer Inst., 81: 1893-1904, 1989.
2. Ronan, S. G , Eng, A. M , Bride, H A., Shioura, N. N., and Das Gupta, T K. Thin malignant melanomas with regression and metastases. Arch Dermatol., 123, 1326-1330, 1987.
3. Gromet, M. A., Epstein, W. L , and Blois, M. S The regressing thin malignant melanoma: a distinctive lesion with metastatic potential. Cancer (Phila.), 42: 2282-2292, 1978.
4. Tefany, F J., Barnetson, S. C. R , Halliday, G M., McCarthy, S W., and McCarthy, W. H. Immunocytochemical analysis of the cellular infiltrate in primary regressing and non-regressing malignant melanoma. J. Invest. Dermatol., 97: 197-202, 1991.
5. Cook, M. G. The significance of inflammation and regression in melanoma Virchows Arch [A], 420, 113-115, 1992.
6. Balch, C. M., Soong, S., Shaw, H. M , Urist, M. M , and McCarthy, W. H. An analysis of prognostic factors in 8500 patients with cutaneous melanoma. In: C. M. Balch, G. W Milton, S. Soong, A. N. Houghton, and A. J. Sober (eds.), Cutaneous Melanoma, Ed. 2, pp. 165-187. Philadelphia J B. Lippincott Co., 1992
7. Schwartz, R. A. Keratoacanthoma. J Am. Acad Dermatol., 30. 1-19, 1994.
8. Kripke, M. L. Immunologic mechanisms in UV radiation carcinogenesis. Adv. Cancer Res., 34: 69-106, 1981.
9. Herlyn, D., Elder, D. E., Bondi, E., Atkinson, B., Guerry, D. I. V., Koprowski, H , and Clark, W. H , Jr Human cutaneous nevi transplanted onto nude mice a model for the study of the lesional steps in tumor progression. Cancer Res., 46. 1339-1343, 1986.
10. Clark, W H., Jr. Human cutaneous malignant melanoma as a model for cancer. Cancer Metastasis Rev., 10: 83-88, 1991.
11. Clark, W. H., Jr. Tumour progression and the nature of cancer. Br. J. Cancer, 64: 631-644, 1991.
12. Clark, W. H., Jr. From the melanocyte to melanoma to tumor biology Adv Cancer Res., 65: 113-140, 1994.
13. Elder, D. E., Rodeck, U., Thurin, J., Cardillo, F., Clark, W. H., Jr., Stewart, R., and Herlyn, M Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas. Cancer Res , 49: 5091-5096, 1989.
14. Clark, W. H., Jr., Elder, D. E., Gerry, D. T., Epstein, M N., Greene, M. H., and Van Horn, M A study of tumor progression the precursor lesions of superficial spreading and nodular melanoma. Hum. Pathol., 15: 1147-1165, 1984
15. Rubin, H. Adaptive evolution of degrees and kinds of neoplastic transformation in cell culture Proc Natl. Acad. Sci. USA, 89, 977-981, 1992.
16. Prehn, R. T. Stimulatory effects of immune reactions upon the growths of untransplanted tumors. Cancer Res., 54, 908-914, 1994.
17. Stubbs, R. H. Haberman, H. H., and Pawlowski, A. Guinea pig cutaneous nevi transplanted to allogeneic nude mice: a potential model for benign and malignant melanocytic lesions Cancer Res., 43, 4448-4452, 1983.
18. Prehn, R. T. Immunostimulation of the lymphodependent phase of neoplastic growth. J Natl. Cancer Inst., 59: 1043-1049, 1977.
19. Barnes, C. J., Lee, M , Hardman, W. E., and Cameron, I. L. Aspirin, age, and proximity to lymphoid nodules influence cell proliferation parameters in rat colonic crypts Cell Prolif., 28: 59-71, 1995
20. Hayflick, L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res., 37: 614-636, 1965.
21. Folkman, J. What is the role of angiogenesis in metastases from cutaneous melanoma? Eur. J. Cancer Clin. Oncol., 23: 361-363, 1987
22. Patel, A., Halliday, G M , Cooke, B. E., and Barnetson, R. S. Evidence that regression in keratoacanthoma is immunologically mediated, a comparison with squamous cell carcinoma. Br. J. Dermatol., 131: 789-798, 1994.
23. Hammond, W. G., Benfield, J. R., Tesluk, H., Johnson, J. R., and Teplitz, R. L. Tumor progression by lung cancers growing in hosts of different immunocompetence. Cancer J., 8: 130-138, 1995
24. Fulton, A M , Loveless, S. E., and Heppner, G. H. Mutagenic activity of tumor-associated macrophages. Cancer Res., 44, 4308-4311, 1984.
25. Mantovani, A , Bortazzi, B., Colotta, F., Sozzani, S., and Ruco, L. The origin and function of tumor-associated macrophages. Immunol. Today, 13: 265-270, 1992.
26. Leibovici, J., and Hoenig, S. Lysis and growth stimulation of a murine melanoma determined by density of macrophage populations. Anticancer Res., 5: 545-552, 1985.
27. Shapiro, J. A Adaptive mutation: who's really in the garden? Science (Washington DC), 268: 373-374, 1995.
28. Prehn, R T. Analysis of antigenic heterogeneity within individual 3- methylcholanthrene-induced mouse sarcomas. J. Natl. Cancer Inst., 45. 1039-1045, 1970.
29. Roholl, P. J M., Rutgers, D. H., Rademakers, L. H. P. M., DeWeger, R A., Elbers, J. R. J. and Van Unnik, J. A. M. Characterization of human soft tissue sarcomas in nude mice. Am. J. Pathol., 131: 559-568, 1988
30. Hadju, S. I , Lemos, C. B., Kozakewich, H., Nelson, L., and Beattie, E. J. Growth pattern and differentiation of human soft tissue tumors in nude mice. Cancer (Phila.), 47: 90-98, 1981.
31. Kreider, J. W., and Schmoyer, M. E. Spontaneous maturation and differentiation of B16 melanoma cells in culture J Natl. Cancer Inst., 55: 641-647, 1975
32. Rubin, H. Experimental control of neoplastic progression in cell populations: Fould's rules revisited. Proc. Natl. Acad. Sci. USA, 91: 6619-6623, 1994.
33. Noble, R. L. Hormonal control of growth and progression in tumors of Nb rats and a theory of action. Cancer Res., 37: 82-94, 1977.
34. Eldredge, N., and Gould, S. J. Punctuated equilibra, an alternative to gradualism. In. T. J M. Schopf (ed.), Models in Paleobiology, pp 82-115. San Francisco: Freeman, Cooper and Co., 1972.
35. Lawerence, N., and Reed, R. J. Actinic keratoacanthoma: speculations on the nature of the lesion and the role of cellular immunity in its evolution. Am. J. Dermatopathol., 12. 517-533, 1990.
36. North, R. J. Down-regulation of the antitumor immune response. Adv. Cancer Res., 45: 1-43, 1985
37. Cartei, G., Sala, P G , Sanzan, M., Ceschia, V., Clocchiarti, L., Sibau, A., Dona, S., Giovannoni, M., and Vigevani, E Reduced lymphocyte subpopulations in patients with advanced or disseminated melanoma J. Am Acad. Dermatol., 28, 738-744, 1993.
38. Manson, L. A. Anti-tumor immune responses of the tumor-bearing host: the case for antibody-mediated immunologic enhancement. Clin. Immunol. Immunopathol., 72: 1-8, 1994.
39. Furth, J. Conditioned and autonomous neoplasms: a review. Cancer Res., 13: 477-492, 1953.
40. Lappé, M A. Evidence for the antigenicity of papillomas induced by 3- methylcholanthrene. J. Natl. Cancer Inst., 40: 823-846, 1968.
41. Lappé, M. A. Evidence for immunological surveillance during skin carcinogenesis. Israel J. Med. Sci., 7: 52-65, 1971.
42. Outzen, H. C. Development of carcinogen-induced skin tumors in mice with varied states of immune capacity. Int J Cancer, 26: 87-92, 1980
43. Andrews, E J. Evidence of the nonimmune regression of chemically induced papillomas in mouse skin. J. Natl. Cancer Inst., 47: 653-665, 1971